Invention Grant
US08541391B2 Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl-1H-benzimidazole
有权
5,6-二氯-2-（异丙基氨基）-1-β-L-呋喃核糖基-1H-苯并咪唑的结晶相
- Patent Title: Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl-1H-benzimidazole
- Patent Title (中): 5,6-二氯-2-（异丙基氨基）-1-β-L-呋喃核糖基-1H-苯并咪唑的结晶相
-
Application No.: US13282504Application Date: 2011-10-27
-
Publication No.: US08541391B2Publication Date: 2013-09-24
- Inventor: Eugene C. Amparo , Cristina Stoica , Mihaela Pop , Jaroslaw Mazurek
- Applicant: Eugene C. Amparo , Cristina Stoica , Mihaela Pop , Jaroslaw Mazurek
- Applicant Address: US PA Exton
- Assignee: ViroPharma Incorporated
- Current Assignee: ViroPharma Incorporated
- Current Assignee Address: US PA Exton
- Agency: Dann, Dorfman, Herrell and Skillman, P.C.
- Agent Patrick J. Hagan
- Main IPC: A01N43/04
- IPC: A01N43/04 ; A61K31/70
Abstract:
The invention relates to novel crystalline forms of 5,6-dichloro-2-(isopropylamino)-1-(β-L-ribofuranosyl)-1H-benzimidazole (Maribavir), pharmaceutical compositions thereof and their use in medical therapy.
Public/Granted literature
- US20120277177A1 CRYSTALLINE PHASES OF 5,6-DICHLORO-2-(ISOPROPYLAMINO)-1-BETA-RIBOFURANOSYL-1H-BENZIMIDAZOLE Public/Granted day:2012-11-01
Information query
IPC分类:
